|
Category:
Description:
Indications:
Contraindications:
-
Severe
toxic CNS depression, coma, subcortical brain damage, bone marrow
depression
-
Severe
liver or cardiac disease, narrow-angle glaucoma, pediatric surgery
Precautions:
-
Pregnancy
category C; evidence indicates safety in low doses; expect sedation in
nursing infants
-
Children
<5 years, prolonged use, cardiovascular disease, epilepsy
-
Hepatic
or renal disease, glaucoma, prostatic hypertrophy, severe asthma
-
Emphysema,
hypocalcemia, thyrotoxicosis, tartrazine sensitivity
Adverse
Reactions (Side Effects):
-
CNS:
agitation, anxiety, catatonic-like behavioral states, confusion,
depression, drowsiness, EPS, euphoria, exacerbation of psychotic
symptoms including hallucinations, headache, heat or cold intolerance,
insomnia, lethargy, neuroleptic malignant syndrome, restlessness,
seizures, vertigo
-
CV:
ECG changes, hypertension, hypotension, tachycardia
-
EENT:
blurred vision, cataracts, dry eyes, dry mouth, glaucoma, pigmentaion
of retina or cornea, retinopathy
-
GI:
anorexia, constipation, diarrhea, dyspepsia, hypersalivation, nausea,
vomiting
-
GU:
priapism, urinary retention
-
HEME:
agranulocytosis, anemia, aplastic anemia, hemolytic anemia,
leukocytosis, transient leukopenia
-
METAB:
breast engorgement, gynecomastia, hyperglycemia, hyperprolactinemia,
hypoglycemia, hyponatremia, impotence, increased libido, lactation,
mastalgia, menstrual irregularities
-
RESP:
bronchospasm, increased depth of respiration, laryngospasm
-
SKIN:
diaphoresis, loss of hair, maculopapular and acneiform skin reactions,
photosensitivity
|
Dosage:
Administered
orally, intramuscularly, intravenously, rectally
-
Adult:
-
Antiemetic:
PO 5-10mg 3-4 times daily, usual max 40mg daily; PO extended
release 10mg 2 times daily or 15mg once daily; IM 5-10mg every 3-4
hours, usual max 40mg daily; IV 2.5-10mg every 3-4 hours, max 10mg
per dose, 40 mg/day; PR 25mg 2 times daily
-
Psychosis:
PO 5-10mg 3-4 times daily, increase dose as needed, max 150mg
daily; IM 10-20mg every 4 hours as needed, convert to PO as soon
as possible
-
Child:
-
Antiemetic:
PO/PR 9-14kg: 2.5mg every 12 –24 hours, max 7.5mg daily;
14-18kg: 2.5mg every 8 hours or 5mg every 12 hours, max 15mg
daily; IM 0.1-0.5 mg/kg/dose, convert to PO as soon as possible
-
Psychosis:
PO/PR 2-12 years: 2.5mg 2-3 times daily, increase dose as
needed, max 20mg daily; 2-5 years: 25mg daily; IM 6-12 years: 0.13
mg/kg/dose, convert to PO as soon as possible
Drug
interactions:
·
Levodopa:
inhibited effect of levodopa on Parkinson’s disease
·
Indomethacin:
possible increased CNS side effects, other NSAIDs less likely to have
effect
·
Narcotic
analgesics: excessive CNS depression, hypotension, respiratory depression
|
Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an
endorsement of the product itself, but simply an acknowledgement of the source.
Operational Medicine 2001
Health Care in Military Settings
Bureau of Medicine and
Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational
Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by
The Brookside Associates Medical Education
Division. It contains original contents from the official US Navy
NAVMED P-5139, but has been reformatted for web access and includes advertising
and links that were not present in the original version. This web version has
not been approved by the Department of the Navy or the Department of Defense.
The presence of any advertising on these pages does not constitute an
endorsement of that product or service by either the US Department of Defense or
the Brookside Associates. The Brookside Associates is a private organization,
not affiliated with the United States Department of Defense.
Contact Us · · Other
Brookside Products
|